All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @lifeaszeph on TikTok · 66s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @lifeaszeph's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Recently got blood work done for my hair and I just got the results so let's go over them.
  2. 0:03This panel is mainly done to check my hormones as I've been on finasteride a DHT blocking
  3. 0:07drug for my hair for over two years.
  4. 0:08I've done seven different things checked so let's go over them.
  5. 0:10This is my testosterone came in at 893.
  6. 0:12This is way higher than I thought it would be.
  7. 0:14Now total testosterone is great but what really matters is your free testosterone.
  8. 0:17Basically what you're able to utilize.
  9. 0:18This came in at a 130.3 which is also pretty high and that's a great sign.
  10. 0:22Now my SHBG came back at a 50.
  11. 0:25This is slightly concerning but still in a normal range.
  12. 0:27The main reason I take finasteride is to block dihydrotestosterone or DHT and although I didn't
  13. 0:31get a baseline measurement of my blood before I hopped on finasteride.
  14. 0:35I still wanted to get all these markers just to get some idea of where I'm at.
  15. 0:38The DHT being the main cause of male pattern baldness I'd preferably want it to be pretty low
  16. 0:42and this is where it's currently at which is also a good sign.
  17. 0:45It's definitely pretty low.
  18. 0:46The only thing I wish I could find is the free dihydrotestosterone and not just the total
  19. 0:50dihydrotestosterone.
  20. 0:51Either way it does come down to the sensitivity of the hair follicle and not how much DHT you have
  21. 0:55but it is a good sign.
  22. 0:56There are the rest of my results.
  23. 0:57Everything seems to be in a normal range and overall mentally and physically I feel great
  24. 1:01and I plan to look into other panels here in the future so I'll keep you guys posted.
  25. 1:04Love y'all peace.

LifeAsZeph's TRT hair growth claims need more context

LifeAsZeph

TikTok creator

238.3K viewsWatch on TikTok

Quick answer

The creator is a young male who has been on finasteride for over two years for androgenetic alopecia, reporting total testosterone of 893 ng/dL, free testosterone of 130.3 pg/mL, and SHBG of 50 nmol/L, with DHT described as suppressed but no numeric value given on screen. The elevated SHBG is a clinically relevant finding worth monitoring, as it reduces bioavailable testosterone and can be modestly influenced by finasteride use. No baseline pre-treatment values exist for comparison, which limits interpretation of the DHT suppression claimed.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For LifeAsZeph's TRT hair growth claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

LifeAsZeph's TRT hair growth claims need more context should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "LifeAsZeph's TRT hair growth claims need more context" from LifeAsZeph. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is a young male who has been on finasteride for over two years for androgenetic alopecia, reporting total testosterone of 893 ng/dL, free testosterone of 130.

The reason this review is not generic is the source wording and the canonical claim label "trt replying to jeffrey dean my resluts hair hairtransformati." In this clip, the useful excerpt is: "Recently got blood work done for my hair and I just got the results so let's go over them." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Free testosterone is more clinically informative than total testosterone when SHBG is elevated, because SHBG binds testosterone and removes it from active circulation.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is a young male who has been on finasteride for over two years for androgenetic alopecia, reporting total testosterone of 893 ng/dL, free testosterone of 130.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is a young male who has been on finasteride for over two years for androgenetic alopecia, reporting total testosterone of 893 ng/dL, free testosterone of 130.3 pg/mL, and SHBG of 50 nmol/L, with DHT described as suppressed but no numeric value given on screen. The elevated SHBG is a clinically relevant finding worth monitoring, as it reduces bioavailable testosterone and can be modestly influenced by finasteride use. No baseline pre-treatment values exist for comparison, which limits interpretation of the DHT suppression claimed.
  • Finasteride reduces serum DHT by approximately 65-70% in clinical trials, but individual response varies and a single post-treatment panel without baseline data cannot confirm personal suppression magnitude (Kaufman et al., 1998, JAAD).
  • Free testosterone is more clinically informative than total testosterone when SHBG is elevated, because SHBG binds testosterone and removes it from active circulation.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Finasteride reduces serum DHT by approximately 65-70% in clinical trials, but individual response varies and a single post-treatment panel without baseline data cannot confirm personal suppression magnitude (Kaufman et al., 1998, JAAD).
  • Free testosterone is more clinically informative than total testosterone when SHBG is elevated, because SHBG binds testosterone and removes it from active circulation.
  • SHBG at 50 nmol/L is within normal range for adult males but is at the higher end and should be monitored over time, especially alongside finasteride use.
  • Follicle androgen receptor sensitivity, not serum DHT alone, determines individual susceptibility to androgenetic alopecia, which is why some men lose hair despite low DHT levels.
  • Post-finasteride syndrome, including persistent sexual dysfunction and mood changes after stopping the drug, is documented in case literature and patient registries and warrants informed consent before starting treatment (Irwig, 2012, Journal of Sexual Medicine).
  • Free DHT testing is not widely standardized in clinical labs, so total serum DHT provides an incomplete picture of androgenic activity at the follicle level.
  • A hormone panel taken mid-treatment is useful for monitoring but should be interpreted by a clinician with full medical history, not used as a standalone self-assessment tool.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @lifeaszeph actually say?

@lifeaszeph shared bloodwork results after two-plus years on finasteride, a DHT-blocking drug used for male pattern hair loss. Their testosterone came in at 893 ng/dL, free testosterone at 130.3 pg/mL, SHBG at 50 nmol/L, and DHT at a level they described as "pretty low." They flagged that SHBG was "slightly concerning but still in a normal range" and acknowledged they had no baseline DHT measurement before starting finasteride. They also noted that hair loss ultimately "comes down to the sensitivity of the hair follicle and not how much DHT you have."

This is a more nuanced take than most hair-loss content on TikTok. They are not selling anything here. They are just walking through a panel and being reasonably transparent about its limitations.

Does the science back this up?

Mostly, yes. Finasteride does suppress DHT, follicle sensitivity does matter, and elevated SHBG does warrant attention. The science is more complicated than a single panel can capture, but the core claims hold up.

Finasteride works by inhibiting 5-alpha reductase type II, the enzyme that converts testosterone to DHT. Clinical trials have consistently shown it reduces serum DHT by roughly 65-70% (Kaufman et al., 1998, Journal of the American Academy of Dermatology). That is the mechanism @lifeaszeph is relying on, and it is legitimate.

The follicle sensitivity point is also real. Androgenetic alopecia is driven by how hair follicles respond to DHT, which is governed by androgen receptor density and sensitivity, not just circulating DHT levels alone (Randall, 2008, Journal of Endocrinology). Some men with low serum DHT still lose hair because their follicles are hyper-responsive. @lifeaszeph got this right, which is more than most influencers do.

What did they get wrong (or right)?

They got the biology mostly right. The SHBG concern is legitimate and worth flagging. The no-baseline problem is real but they admitted it directly, which earns credit. The one gap is the free DHT point, which deserves more attention than it got.

SHBG at 50 nmol/L is on the higher end of normal for most lab ranges (typically 10-57 nmol/L). Elevated SHBG binds more testosterone, reducing the free fraction available to tissues. Their free testosterone at 130.3 pg/mL is still in a reasonable range, but if SHBG climbs further, that could become clinically relevant. Finasteride itself has been associated with modest SHBG increases in some studies (Traish et al., 2011, Journal of Sexual Medicine).

The free DHT point is the most substantive gap. Total serum DHT does not tell you what is happening at the follicle level. Free DHT and tissue DHT levels are harder to measure but more relevant. @lifeaszeph acknowledged this, which is honest. But it also means their "pretty low" DHT reading tells an incomplete story.

What should you actually know?

A hormone panel taken after two years on finasteride, without a pre-treatment baseline, tells you where you are, not what finasteride did to you. That is a meaningful distinction if you are trying to evaluate the drug's effect on your body.

For context: finasteride has a real and documented side effect profile. Post-finasteride syndrome, characterized by persistent sexual dysfunction, depression, and cognitive symptoms after stopping the drug, remains contested but is documented in case literature and increasingly in patient registries (Irwig, 2012, Journal of Sexual Medicine). The drug works for most men who take it. It also causes persistent problems for a minority. That is the trade-off, and it is worth knowing before you start, not two years in.

SHBG also interacts with how you interpret any testosterone panel. High SHBG inflates total testosterone numbers while reducing bioavailable testosterone. If someone is optimizing for "feeling great," tracking free testosterone and SHBG together over time is more informative than a single snapshot.

Should you get this panel if you are on finasteride?

Getting bloodwork while on finasteride is a reasonable idea. The specific panel here is a starting point, not a complete picture.

  • Total and free testosterone give you baseline hormonal context, but SHBG needs to be interpreted alongside them, not in isolation.
  • Total DHT is useful but limited. Free DHT testing is not widely standardized, which is why most labs do not offer it routinely.
  • Liver function markers and a complete metabolic panel are worth adding if you are on any long-term medication, finasteride included.
  • Sexual function and mood should be monitored alongside labs. Bloodwork does not capture everything finasteride can affect (Irwig and Kolukula, 2011, Journal of Sexual Medicine).
  • A prescribing clinician, not a TikTok panel review, should interpret these results in the context of your full history.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

LifeAsZeph · TikTok creator

238.3K views on this video

Replying to @Jeffrey Dean my resluts #hair #hairtransformation #update #hairgrowth

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about finasteride reduces serum dht by approximately 65-70% in clinical trials,?

Finasteride reduces serum DHT by approximately 65-70% in clinical trials, but individual response varies and a single post-treatment panel without baseline data cannot confirm personal suppression magnitude (Kaufman et al., 1998, JAAD).

What does the video say about free testosterone?

Free testosterone is more clinically informative than total testosterone when SHBG is elevated, because SHBG binds testosterone and removes it from active circulation.

What does the video say about shbg at 50 nmol/l?

SHBG at 50 nmol/L is within normal range for adult males but is at the higher end and should be monitored over time, especially alongside finasteride use.

What does the video say about follicle?

Follicle androgen receptor sensitivity, not serum DHT alone, determines individual susceptibility to androgenetic alopecia, which is why some men lose hair despite low DHT levels.

What does the video say about post-finasteride syndrome, including persistent sexual dysfunction?

Post-finasteride syndrome, including persistent sexual dysfunction and mood changes after stopping the drug, is documented in case literature and patient registries and warrants informed consent before starting treatment (Irwig, 2012, Journal of Sexual Medicine).

What does the video say about free dht testing?

Free DHT testing is not widely standardized in clinical labs, so total serum DHT provides an incomplete picture of androgenic activity at the follicle level.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by LifeAsZeph, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.